Finance

Lists
603087:SHA
Gan & Lee Pharmaceuticals
69,81 CNY
+0,45%
(+0,31) 1D
16 ოქტ, 15:00:02 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603087...
Open
70,25 CNY
High
73,00 CNY
Low
68,91 CNY
Mkt. cap
41,52 მლრდ.
Avg. vol.
7,43 მლნ.
Volume
9,10 მლნ.
Dividend
1,43%
Quarterly dividend
0,25 CNY
Ex-dividend date
29 მაი. 2026
P/E ratio
36,07
52-wk high
79,99 CNY
52-wk low
51,51 CNY
EPS
1,94 CNY
No. of employees
5 ათ.
Open
70,25 CNY
High
73,00 CNY
Low
68,91 CNY
Mkt. cap
41,52 მლრდ.
Avg. vol.
7,43 მლნ.
Volume
9,10 მლნ.
Dividend
1,43%
Quarterly dividend
0,25 CNY
Ex-dividend date
29 მაი. 2026
P/E ratio
36,07
52-wk high
79,99 CNY
52-wk low
51,51 CNY
EPS
1,94 CNY
No. of employees
5 ათ.
News stories
From web sources and news partners
The Frederick News-Post
The Frederick News-Post
·
14 წუთის წინ
US markets are weighed down by an extended sell-off in the tech sector
MarketWatch
MarketWatch
·
7 საათის წინ
Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks
CNN
CNN
·
8 საათის წინ
Nasdaq sinks more than 2% as investors raise questions about AI debt
Yahoo Finance
Yahoo Finance
·
2 საათის წინ
Dow (DOW) Stock Could Look Reasonable After a 43% Gain
About Gan & Lee Pharmaceuticals
CEO-
Employees5,31 ათ.
Founded17 ივნ. 1998
Headquarters-
Sector-
Websiteganlee.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
980,24 მლნ.
1,01 მლრდ.
878,11 მლნ.
1,34 მლრდ.
Cost of goods sold
234,89 მლნ.
259,72 მლნ.
223,40 მლნ.
359,10 მლნ.
Cost of revenue
234,89 მლნ.
259,72 მლნ.
223,40 მლნ.
359,10 მლნ.
Research and development expenses
143,34 მლნ.
239,11 მლნ.
128,04 მლნ.
170,06 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
384,60 მლნ.
444,21 მლნ.
327,25 მლნ.
377,07 მლნ.
Operating expense
527,76 მლნ.
709,00 მლნ.
462,53 მლნ.
557,24 მლნ.
Total operating expenses
762,65 მლნ.
968,72 მლნ.
685,94 მლნ.
916,35 მლნ.
Operating income
217,59 მლნ.
36,39 მლნ.
192,17 მლნ.
428,57 მლნ.
Other non operating income
56,64 მლნ.
-70,56 მლნ.
-1,12 მლნ.
3,22 მლნ.
EBT including unusual items
234,69 მლნ.
304,10 მლნ.
212,64 მლნ.
474,46 მლნ.
EBT excluding unusual items
290,23 მლნ.
257,75 მლნ.
205,87 მლნ.
465,75 მლნ.
Income tax expense
20,03 მლნ.
-21,15 მლნ.
20,18 მლნ.
57,59 მლნ.
Effective tax rate
8,53%
-6,95%
9,49%
12,14%
Other operating expenses
-209,47 ათ.
25,46 მლნ.
7,75 მლნ.
9,04 მლნ.
Net income
214,66 მლნ.
325,24 მლნ.
192,49 მლნ.
417,29 მლნ.
Net profit margin
21,90%
32,36%
21,92%
31,03%
Earnings per share
-
-
-
-
Interest and investment income
16,11 მლნ.
303,56 მლნ.
14,82 მლნ.
55,17 მლნ.
Interest expense
-
-231,14 ათ.
-
-102,21 ათ.
Net interest expenses
16,11 მლნ.
303,33 მლნ.
14,82 მლნ.
55,07 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
280,34 მლნ.
110,65 მლნ.
266,44 მლნ.
519,60 მლნ.
Gain or loss from assets sale
-
-3,71 მლნ.
-
54,15 ათ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები